These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7565632

  • 1. Effects of gamma-glutamyl hydrolase on folyl and antifolylpolyglutamates in cultured H35 hepatoma cells.
    Yao R, Rhee MS, Galivan J.
    Mol Pharmacol; 1995 Sep; 48(3):505-11. PubMed ID: 7565632
    [Abstract] [Full Text] [Related]

  • 2. Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity.
    Rhee MS, Wang Y, Nair MG, Galivan J.
    Cancer Res; 1993 May 15; 53(10 Suppl):2227-30. PubMed ID: 7683570
    [Abstract] [Full Text] [Related]

  • 3. The role of folylpolyglutamate synthetase and gamma-glutamyl hydrolase in altering cellular folyl- and antifolylpolyglutamates.
    Galivan J, Johnson T, Rhee M, McGuire JJ, Priest D, Kesevan V.
    Adv Enzyme Regul; 1987 May 15; 26():147-55. PubMed ID: 3499766
    [Abstract] [Full Text] [Related]

  • 4. Secretion of gamma-glutamyl hydrolase in vitro.
    O'Connor BM, Rotundo RF, Nimec Z, McGuire JJ, Galivan J.
    Cancer Res; 1991 Aug 01; 51(15):3874-81. PubMed ID: 1713122
    [Abstract] [Full Text] [Related]

  • 5. Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells.
    Johnson TB, Nair MG, Galivan J.
    Cancer Res; 1988 May 01; 48(9):2426-31. PubMed ID: 2451560
    [Abstract] [Full Text] [Related]

  • 6. Glutamyl hydrolase: properties and pharmacologic impact.
    Galivan J, Ryan T, Rhee M, Yao R, Chave K.
    Semin Oncol; 1999 Apr 01; 26(2 Suppl 6):33-7. PubMed ID: 10598552
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration.
    Jansen G, Barr H, Kathmann I, Bunni MA, Priest DG, Noordhuis P, Peters GJ, Assaraf YG.
    Mol Pharmacol; 1999 Apr 01; 55(4):761-9. PubMed ID: 10101035
    [Abstract] [Full Text] [Related]

  • 9. Insulin-dependent suppression in glutamyl hydrolase activity and elevated cellular methotrexate polyglutamates.
    Galivan J, Rhee MS.
    Biochem Pharmacol; 1995 Nov 09; 50(10):1659-63. PubMed ID: 7503769
    [Abstract] [Full Text] [Related]

  • 10. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse.
    Samuels LL, Goutas LJ, Priest DG, Piper JR, Sirotnak FM.
    Cancer Res; 1986 May 09; 46(5):2230-5. PubMed ID: 2421872
    [Abstract] [Full Text] [Related]

  • 11. Glutamyl hydrolase. pharmacological role and enzymatic characterization.
    Galivan J, Ryan TJ, Chave K, Rhee M, Yao R, Yin D.
    Pharmacol Ther; 2000 Mar 09; 85(3):207-15. PubMed ID: 10739875
    [Abstract] [Full Text] [Related]

  • 12. Gamma-glutamyl hydrolase and drug resistance.
    Schneider E, Ryan TJ.
    Clin Chim Acta; 2006 Dec 09; 374(1-2):25-32. PubMed ID: 16859665
    [Abstract] [Full Text] [Related]

  • 13. Synergistic effect of 5-fluorodeoxyuridine and quinazoline antifolates on murine leukemia self-cultured in vitro.
    Balińska M, Szablewska I, Janiszewska D, Brzezińska A, Pawełczak K.
    Acta Biochim Pol; 1997 Dec 09; 44(4):735-42. PubMed ID: 9584853
    [Abstract] [Full Text] [Related]

  • 14. Mechanism-based inhibitors of folylpoly-gamma-glutamate synthetase and gamma-glutamyl hydrolase: control of folylpoly-gamma-glutamate homeostasis as a drug target.
    Coward JK, McGuire JJ.
    Vitam Horm; 2008 Dec 09; 79():347-73. PubMed ID: 18804701
    [Abstract] [Full Text] [Related]

  • 15. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.
    Peters GJ, Smitskamp-Wilms E, Smid K, Pinedo HM, Jansen G.
    Cancer Res; 1999 Nov 01; 59(21):5529-35. PubMed ID: 10554030
    [Abstract] [Full Text] [Related]

  • 16. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
    Pizzorno G, Moroson BA, Cashmore AR, Russello O, Mayer JR, Galivan J, Bunni MA, Priest DG, Beardsley GP.
    Cancer Res; 1995 Feb 01; 55(3):566-73. PubMed ID: 7834626
    [Abstract] [Full Text] [Related]

  • 17. The properties of the secreted gamma-glutamyl hydrolases from H35 hepatoma cells.
    Wang Y, Nimec Z, Ryan TJ, Dias JA, Galivan J.
    Biochim Biophys Acta; 1993 Aug 07; 1164(3):227-35. PubMed ID: 8343522
    [Abstract] [Full Text] [Related]

  • 18. New methods for the study of folate coenzymes: endogenous polyglutamate patterns of subcellular hepatocyte fractions and of regenerating rat liver.
    Krumdieck CL, Eto I, Krumdieck R.
    Adv Exp Med Biol; 1983 Aug 07; 163():115-37. PubMed ID: 6613724
    [Abstract] [Full Text] [Related]

  • 19. Folate polyglutamate and monoglutamate accumulation in normal and SV40-transformed human fibroblasts.
    Hoffman RM, Coalson DW, Jacobsen SJ, Erbe RW.
    J Cell Physiol; 1981 Dec 07; 109(3):497-505. PubMed ID: 6274882
    [Abstract] [Full Text] [Related]

  • 20. Folate analogues. 33. Synthesis of folate and antifolate poly-gamma-glutamates by [(9-fluorenylmethoxy)oxy]carbonyl chemistry and biological evaluation of certain methotrexate polyglutamate polylysine conjugates as inhibitors of the growth of H35 hepatoma cells.
    Abraham A, Nair MG, Kisliuk RL, Gaumont Y, Galivan J.
    J Med Chem; 1990 Feb 07; 33(2):711-7. PubMed ID: 1688946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.